Analysis of COVID‐19 vaccines: types, thoughts, and application

X Han, P Xu, Q Ye - Journal of clinical laboratory analysis, 2021 - Wiley Online Library
Objective To deal with COVID‐19, various countries have made many efforts, including the
research and development of vaccines. The purpose of this manuscript was to summarize …

[HTML][HTML] COVID-19 vaccines

D Ndwandwe, CS Wiysonge - Current opinion in immunology, 2021 - Elsevier
Highlights•COVID-19 vaccine development has accelerated at an incredible rate with 105
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …

[HTML][HTML] Review of COVID-19 vaccines approved in the United States of America for emergency use

D Vasireddy, P Atluri, SV Malayala… - Journal of clinical …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus
causing a global pandemic. Coronaviruses are a large family of single-stranded ribonucleic …

Current and future perspectives on the COVID-19 vaccine: a scientometric review

A Noruzi, B Gholampour, S Gholampour… - Journal of Clinical …, 2022 - mdpi.com
This study attempted to draw the present and future perspective of the COVID-19 vaccine by
identifying the most important scientists and their scientific contexts, trends of research …

COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations

Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

[HTML][HTML] The find of COVID-19 vaccine: Challenges and opportunities

M ElBagoury, MM Tolba, HA Nasser, A Jabbar… - Journal of infection and …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus (SARS-CoV-2), a novel corona virus,
causing COVID-19 with Flu-like symptoms is the first alarming pandemic of the third …

COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic

AA Zasada, A Darlińska, A Wiatrzyk, K Woźnica… - Viruses, 2023 - mdpi.com
The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …

[PDF][PDF] COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

SA Meo, IA Bukhari, J Akram, AS Meo… - European Review for …, 2021 - europeanreview.org
OBJECTIVE: The “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)”
disease has caused a worldwide challenging and threatening pandemic (COVID-19), with …

[HTML][HTML] Innovations and development of COVID-19 vaccines: A patent review

AS Alshrari, SA Hudu, M Imran, SMB Asdaq… - Journal of infection and …, 2022 - Elsevier
More than 125 million confirmed cases of COVID-19 have been reported globally with rising
cases in all countries since the first case was reported. A vaccine is the best measure for the …

COVID-19 vaccine: where are we now and where should we go?

S Soleimanpour, A Yaghoubi - Expert review of vaccines, 2021 - Taylor & Francis
Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …